InMode Ltd.

InMode Ltd. designs, develops, manufactures, and markets minimally invasive and non-invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies. Its minimally invasive products are used for procedures such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation, as well as for women's health conditions. The company also offers non-invasive products targeting permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, and superficial vascular and pigmented lesions. Additionally, InMode provides hands-free medical aesthetic products for skin tightening, fat reduction, and muscle stimulation.

InMode Ltd. is listed on the Nasdaq Global Select Market (NasdaqGS) under the ticker symbol INMD. Its shares are traded in US dollars (USD). The company is headquartered in Yokne'am, Israel, and its stock is accessible to investors through the US exchange, making it part of the US region for trading purposes.

InMode Ltd. operates in the Healthcare sector and is classified under the Medical Devices industry. This means the company develops and markets medical devices, specifically focusing on aesthetic and minimally invasive technologies. Its products are used in medical and cosmetic procedures, combining healthcare and technology to address skin, body contouring, and women's health needs.

InMode Ltd. is headquartered in Yokne'am, Israel, and was incorporated in 2008 (formerly known as Invasix Ltd. before rebranding in November 2017). The company sells and markets its products globally, with direct operations in the United States, Canada, the United Kingdom, Ireland, Spain, Portugal, France, Belgium, Luxembourg, Italy, Germany, Austria, Japan, Australia, and India. It also reaches additional markets through distributors.

InMode Ltd. generates revenue by designing, manufacturing, and selling minimally invasive and non-invasive aesthetic medical products. Its product portfolio includes devices for liposuction, skin tightening, body and face contouring, hair reduction, wrinkle reduction, cellulite treatment, and muscle stimulation. The company sells directly to customers in key markets like the US, Canada, and parts of Europe and Asia, and also uses distributors in other regions. Revenue comes from the sale of capital equipment and related consumables or services.